# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Beta Thalassemia

Beta-ThalassemiaThalassemia Major
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 53 results.
Choroidal Thickness in Beta-thalassemia Patients
Status: Recruiting
Last Changed: Aug 26, 2019
First Received: Aug 26, 2019
Disease(s): Beta-Thalassemia
Intervention(s): EDI-OCT
Locations: Department of Ophthalmology, General University Hospital of Patras, Patras, Achaea, Greece
Dermatological Abnormalities in Beta-thalassemia Major
Status: Not yet recruiting
Last Changed: Mar 28, 2019
First Received: Mar 28, 2019
Disease(s): Beta-Thalassemia
Intervention(s): thalassemia
Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector
Status: Not yet recruiting
Last Changed: Nov 30, 2017
First Received: Nov 24, 2017
Disease(s): Beta-Thalassemia
Intervention(s): Gene-modified autologous stem cells
Locations: Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Detection Of β-thalassemia Carriers In Assiut
Status: Not yet recruiting
Last Changed: Jan 30, 2019
First Received: Jan 30, 2019
Disease(s): Beta-Thalassemia
Intervention(s): CBC, Iron Study, Serum Ferrittin, HPLC,Genitic Study
Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients
Status: Recruiting
Last Changed: Jul 02, 2019
First Received: Mar 18, 2019
Disease(s): Beta-Thalassemia
Intervention(s): Sirolimus 0.5 mg
Locations: Department of Life Sciences and Biotechnology, Section of Biochemistry and Molecular Biology, Ferrara, Italy
Department of Growth and Reproduction Azienda Ospedaliero-Universitaria S.Anna, Ferrara, Italy
Phase 2a Pilot Study to Explore Safety and Efficacy of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation
Status: Not yet recruiting
Last Changed: Sep 17, 2019
First Received: Sep 17, 2019
Disease(s): Beta Thalassemia Major
Intervention(s): Emeramide
A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia
Status: Recruiting
Last Changed: Jul 30, 2019
First Received: Jul 02, 2017
Disease(s): Beta-Thalassemia
Intervention(s): LentiGlobin BB305 Drug Product
Locations: UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Hopital d'enfants de la Timone, Marseille, France
Hannover Medical School, Hannover, Germany
... and 5 other locations.
Apotransferrin in Patients With β-thalassemia
Status: Recruiting
Last Changed: Jun 20, 2019
First Received: Jun 20, 2019
Disease(s): β-thalassemia Intermedia
Intervention(s): human apotransferrin
Locations: Academic Medical Centre, Amsterdam-Zuidoost, Noord-Holland, Netherlands
A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Subjects With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype
Status: Recruiting
Last Changed: Jul 30, 2019
First Received: Sep 20, 2016
Disease(s): Beta-Thalassemia
Intervention(s): LentiGlobin BB305 Drug Product
Locations: Oakland, California, United States
Chicago, Illinois, United States
Philadelphia, Pennsylvania, United States
Marseille, France
Hannover, Germany
... and 5 other locations.
Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified
Status: Not yet recruiting
Last Changed: Sep 08, 2017
First Received: Sep 08, 2017
Disease(s): Beta Thalassemia Major
Intervention(s): Autologous CD34+ cells genetically modified
Locations: Nanfang Hospial, Guangzhou, Guangdong, China